Jie Li from 212 Deer Meadow Ln APT F, Rockville, MD 20850

Professional Records

Medicine Doctors

Jie Li

View page

License Records

Jie Li

Phone:

(973) 978-0320

License #:

9382387 - Active

Category:

Health Care

Issued Date:

May 13, 2014

Effective Date:

May 13, 2014

Expiration Date:

Apr 30, 2018

Type:

Registered Nurse

Lawyers & Attorneys

Jie Li, Washington DC - Lawyer

View page

Address:

888 16Th St Nw Ste 800, Washington, DC 20006
(202) 684-8258 (Office)

Licenses:

Dist. of Columbia - Active 2011

Jie Li - Lawyer

View page

Specialties:

Bankruptcy & Debt
Commercial
Compensation
Benefits
Corporate & Incorporation
Structured Finance

ISLN:

917426399

Admitted:

2004

University:

University of Michigan, B.S., 1998

Law School:

University of Chicago, J.D., 2003

Resumes

Jie Li Perry Hall, MD

View page

Work:

US Food and Drug Administration
Bethesda, MD
2010 to 2012
Researcher
Johns Hopkins University School of Medicine
Baltimore, MD
2004 to 2010
Postdoctoral Fellow
Osaka University

2001 to 2004
Research Associate
Guangdong Province Center for Disease Control and Prevention
Guangzhou, CN
1988 to 1997
Public Health Doctor

Education:

Osaka University Graduate School of Medicine
2002
Ph.D. in Medical Science
Sun Yat-Sen University of Medical Sciences
1988
Bachelor in Medicine

Skills:

FACS, ELISA, cell culture,immunohistochemistry, immunofluorescence microscopy, molecular biology

Business Records

Name / Title

Company / Classification

Phones & Addresses

Jie Li
Vice President Of Operations

I T S C
Engineering Services

9658 Baltimore Ave, College Park, MD 20740

Jie Biao Li
President

USA DEWELLBON INT'L GROUP LIMITED

Jie Li

MJ INTERACTIVE, LLC

Jie Li

JINSHENGYA INDUSTRY COMPANY USA, INC

Jie Li
Director

Rodobo International, Inc

Jie Li
VP

Panda Energy Management Corporation - Delaware
Electrical Contractor Electric Services Combination Utilities

(972) 980-7159

Use Of Phosphatases To Treat Tumors Overexpressing N-Cor

View page

US Patent:

20080214569, Sep 4, 2008

Filed:

Feb 8, 2007

Appl. No.:

11/703401

Inventors:

Zhengping Zhuang - Bethesda MD, US
Edward H. Oldfield - Philmont VA, US
Deric M. Park - Pittsburgh PA, US
Irina Lubensky - Potomac MD, US
Jie Li - Gaithersburg MD, US
John S. Kovach - East Setauket NY, US

International Classification:

A61K 31/496
C12Q 1/02
G01N 33/50
A61P 35/00

US Classification:

51425501, 435 29, 436 86

Abstract:

This invention provides a method of treating a patient suffering from a tumor overexpressing N—CoR comprising administering to the patient a phosphatase ligand, alone or in combination with a retinoid receptor ligand, a histone deacetylase ligand, or both, in amounts effective to treat the patient. This invention also provides a method of inhibiting tumor growth in a patient suffering from a tumor overexpressing N—CoR. This invention further provides a method of identifying a compound or a mixture of compounds capable of inducing differentiation of cells of a tumor overexpressing N—CoR. This invention still further provides a method of determining the likelihood of successfully treating a subject suffering from a tumor overexpressing N—CoR. This invention also provides a method of assessing the likelihood that a patient is suffering from a tumor overexpressing N—CoR. This invention yet also provides a method of assessing the likelihood that a patient previously suffering from and treated for a tumor overexpressing N—CoR has suffered a recurrence of a tumor overexpressing N—CoR. Finally, this invention provides analogous methods for use on glioblastoma multiforme.

Videos & Images